Citation 39818

MA,WW: ANDERSON,JE: MC LAUGHLIN,JL:. (1991). BIOACTIVE BENZYL BENZOATES FROM THE ROOTS OF ENDLICHERIA DYSODANTHA.. 29(3)

Citation Details

Title	BIOACTIVE BENZYL BENZOATES FROM THE ROOTS OF ENDLICHERIA DYSODANTHA.
Authors	MA,WW: ANDERSON,JE: MC LAUGHLIN,JL:
Year	1991
Volume	29
Issue	3

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (1)

Endlicheria dysodantha (LAURACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
3	CROWN GALL TUMOR INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	ACTIVE
7	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	BENZYL BENZOATE,2-HYDROXY:	None
8	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-HYDROXY:	ACTIVE
9	CROWN GALL TUMOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-HYDROXY:	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-HYDROXY:	WEAK ACTIVITY
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-HYDROXY:	WEAK ACTIVITY
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-HYDROXY:	WEAK ACTIVITY
13	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	BENZYL BENZOATE,2-HYDROXY-6-METHOXY:	None
14	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-HYDROXY-6-METHOXY:	ACTIVE
15	CROWN GALL TUMOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-HYDROXY-6-METHOXY:	ACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-HYDROXY-6-METHOXY:	INACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-HYDROXY-6-METHOXY:	WEAK ACTIVITY
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-HYDROXY-6-METHOXY:	WEAK ACTIVITY
19	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	BENZYL BENZOATE,2-6-DIMETHOXY:	None
20	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-6-DIMETHOXY:	ACTIVE
21	CROWN GALL TUMOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-6-DIMETHOXY:	ACTIVE
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-6-DIMETHOXY:	WEAK ACTIVITY
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-6-DIMETHOXY:	WEAK ACTIVITY
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-6-DIMETHOXY:	WEAK ACTIVITY
25	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	BENZYL BENZOATE,2-5-DIMETHOXY:	None
26	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-5-DIMETHOXY:	ACTIVE
27	CROWN GALL TUMOR INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-5-DIMETHOXY:	INACTIVE
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-5-DIMETHOXY:	INACTIVE
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-5-DIMETHOXY:	INACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZYL BENZOATE,2-5-DIMETHOXY:	WEAK ACTIVITY

Citation 39818

Citation Details

Summary

Organisms and Their Experiments (1)

Endlicheria dysodantha (LAURACEAE)

Show SPARQL Queries (1)

Query 1